- Home
- MDGL vs INTA Comparison
MDGL vs INTA Comparison
Compare MDGL & INTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- INTA
- Stock Information
- Founded
- MDGL 2011
- INTA 2000
- Country
- MDGL United States
- INTA United States
- Employees
- MDGL N/A
- INTA N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- INTA Computer Software: Prepackaged Software
- Sector
- MDGL Health Care
- INTA Technology
- Exchange
- MDGL Nasdaq
- INTA Nasdaq
- Market Cap
- MDGL 6.8B
- INTA 5.6B
- IPO Year
- MDGL N/A
- INTA 2021
- Fundamental
- Price
- MDGL $290.96
- INTA $58.07
- Analyst Decision
- MDGL Strong Buy
- INTA Buy
- Analyst Count
- MDGL 10
- INTA 11
- Target Price
- MDGL $420.63
- INTA $66.33
- AVG Volume (30 Days)
- MDGL 361.7K
- INTA 580.1K
- Earning Date
- MDGL 05-01-2025
- INTA 05-06-2025
- Dividend Yield
- MDGL N/A
- INTA N/A
- EPS Growth
- MDGL N/A
- INTA N/A
- EPS
- MDGL N/A
- INTA N/A
- Revenue
- MDGL $317,383,000.00
- INTA $483,457,000.00
- Revenue This Year
- MDGL $264.55
- INTA $18.75
- Revenue Next Year
- MDGL $67.21
- INTA $14.42
- P/E Ratio
- MDGL N/A
- INTA N/A
- Revenue Growth
- MDGL N/A
- INTA 17.70
- 52 Week Low
- MDGL $200.08
- INTA $30.42
- 52 Week High
- MDGL $377.46
- INTA $77.74
- Technical
- Relative Strength Index (RSI)
- MDGL 40.85
- INTA 56.84
- Support Level
- MDGL $280.00
- INTA $55.10
- Resistance Level
- MDGL $307.54
- INTA $58.22
- Average True Range (ATR)
- MDGL 15.97
- INTA 2.24
- MACD
- MDGL -2.00
- INTA 0.52
- Stochastic Oscillator
- MDGL 15.88
- INTA 86.95
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About INTA Intapp Inc.
Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital, investment banking, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.